Profile data is unavailable for this security.
About the company
Medicure Inc. is a pharmaceutical company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. Its primary focus is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through its United States subsidiary, Medicure Pharma Inc. It operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medications for all Americans, together with customer service and free home delivery. It operates Gateway Medical Pharmacy, located in Portland, Oregon in a medical office building near transportation lines and multiple healthcare clinics and centers. It develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, and compositions containing P5P Analogues.
- Revenue in CAD (TTM)26.21m
- Net income in CAD-3.43m
- Incorporated2000
- Employees23.00
- LocationMedicure Inc1250 Waverley StreetWINNIPEG R3T 6C6CanadaCAN
- Phone+1 (204) 487-7412
- Fax+1 (204) 487-7412
- Websitehttps://www.medicure.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Marvel Biosciences Corp | 0.00 | -2.28m | 7.54m | -- | -- | -- | -- | -- | -0.045 | -0.045 | 0.00 | -0.0635 | 0.00 | -- | -- | -- | -499.17 | -239.13 | -- | -- | -- | -- | -- | -- | -- | -4.89 | -- | -- | -- | -- | -34.02 | -- | -- | -- |
| COSCIENS Biopharma Inc | 12.41m | -20.44m | 8.95m | 21.00 | -- | 1.28 | -- | 0.7207 | -6.48 | -6.48 | 3.93 | 2.19 | 0.2678 | 1.96 | 5.18 | -- | -44.08 | -24.51 | -53.74 | -27.91 | 45.14 | 62.83 | -164.63 | -175.84 | 3.03 | -- | 0.2994 | -- | 34.22 | 78.30 | -339.28 | -- | -- | -- |
| Medicure Inc | 26.21m | -3.43m | 12.00m | 23.00 | -- | 0.6934 | -- | 0.458 | -0.3286 | -0.3286 | 2.51 | 1.66 | 0.9492 | 3.90 | 5.93 | 1,139,435.00 | -12.42 | -5.22 | -17.87 | -7.48 | 47.67 | 60.98 | -13.08 | -8.17 | 1.00 | -- | 0.0546 | -- | 0.9818 | 1.66 | -12.69 | -- | -44.35 | -- |
| Innovotech Inc | 4.46m | 383.40k | 14.70m | 16.00 | 28.27 | 5.11 | 30.02 | 3.30 | 0.0096 | 0.0096 | 0.0923 | 0.0529 | 1.85 | 19.32 | 7.96 | -- | 15.26 | 6.12 | 18.38 | 7.33 | 47.12 | 65.29 | 8.27 | 5.49 | 4.45 | -- | 0.00 | -- | 85.56 | 17.35 | 242.62 | -- | 141.95 | -- |
| Sirona Biochem Corp | -16.37k | -2.67m | 15.82m | -- | -- | -- | -- | -- | -0.0105 | -0.0105 | -0.00006 | -0.0134 | -0.0171 | -- | 1.61 | -- | -278.90 | -173.09 | -- | -383.49 | -- | -- | -- | -1,405.28 | -- | -5.73 | -- | -- | -94.82 | -51.37 | 28.52 | -- | -- | -- |
| Numinus Wellness Inc | 5.33m | -10.67m | 16.32m | 35.00 | -- | -- | -- | 3.06 | -0.0366 | -0.0481 | 0.0175 | -0.0049 | 0.5827 | -- | 3.41 | -- | -116.67 | -77.90 | -231.32 | -88.05 | 44.96 | 31.24 | -200.23 | -325.94 | -- | -- | 3.02 | -- | -82.02 | -- | 51.75 | -- | -- | -- |
| Neurothera Labs Inc | 0.00 | -209.09k | 16.98m | -- | -- | 4.06 | -- | -- | -0.0116 | -0.0116 | 0.00 | 0.0493 | 0.00 | -- | -- | -- | -19.28 | -- | -21.28 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -143.95 | -- | -- | -- |
| Hemostemix Inc | 0.00 | -3.40m | 17.57m | -- | -- | -- | -- | -- | -0.03 | -0.03 | 0.00 | -0.0188 | 0.00 | -- | -- | -- | -453.77 | -579.31 | -- | -- | -- | -- | -- | -- | -- | -6.01 | -- | -- | -- | -- | -4.57 | -- | -- | -- |
